Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.5B | 5.3B | 5.7B | 5.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 356.4M | 425.2M | 336.7M | 360.9M |
Other operating expenses | 93.6M | 101.5M | 118.7M | 102.6M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.6B | 2.4B | 2.7B | 2.7B |
Tax provision | 599.4M | 508.7M | 657.0M | 720.9M |
Net income | 2.0B | 1.9B | 2.1B | 2.0B |
Basic EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Diluted EPS | 0.2 | 0.2 | 0.2 | 0.2 |
Basic average shares | 10.7B | 10.7B | 10.7B | 10.7B |
Diluted average shares | 10.8B | 10.8B | 10.8B | 10.7B |
EBITDA | — | — | — | — |
Net income from continuing op. | 2.6B | 2.4B | 2.7B | 2.7B |
Minority interests | -54.3M | -53.3M | -43.2M | -47.8M |
Preferred stock dividends | — | — | — | — |